Katsuhiko Nosho Selected Research

Cyclooxygenase 2 (Cyclooxygenase-2)

11/2018	Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.
10/2018	Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells.
11/2016	Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
10/2012	Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.
3/2011	Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: Cohort study and literature review.
11/2010	Cathepsin B expression and survival in colon cancer: implications for molecular detection of neoplasia.
6/2010	CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
5/2010	Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors.
5/2010	HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers.
3/2010	PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Katsuhiko Nosho Research Topics

Disease

71	Neoplasms (Cancer) 01/2021 - 09/2003
58	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 02/2003
42	Microsatellite Instability 01/2019 - 07/2007
18	Colonic Neoplasms (Colon Cancer) 12/2018 - 02/2003
17	Carcinogenesis 01/2019 - 12/2004
10	Adenoma (Adenomas) 09/2015 - 12/2004
8	Carcinoma (Carcinomatosis) 12/2018 - 02/2003
6	Stomach Neoplasms (Stomach Cancer) 01/2018 - 03/2004
5	Genomic Instability 05/2010 - 09/2006
3	Rectal Neoplasms (Rectal Cancer) 11/2018 - 12/2010
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2017 - 11/2005
3	Neoplasm Metastasis (Metastasis) 03/2016 - 02/2003
3	Polyps 08/2014 - 01/2008
2	Adenocarcinoma 01/2017 - 02/2014
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2017 - 06/2012
2	Inflammation (Inflammations) 11/2016 - 03/2010
2	Lymphatic Metastasis 09/2015 - 05/2008
2	Esophageal Squamous Cell Carcinoma 02/2014 - 05/2007
2	Esophageal Neoplasms (Esophageal Cancer) 02/2014 - 11/2005
2	Breast Neoplasms (Breast Cancer) 01/2014 - 04/2011
2	Obesity 09/2009 - 07/2009
2	Chromosomal Instability (Chromosome Stability) 05/2009 - 01/2009
1	Enteritis 06/2018
1	Proctitis 02/2018
1	Aortic Rupture 02/2018
1	Pathologic Constriction (Stenosis) 02/2018
1	Bile Duct Neoplasms (Bile Duct Cancer) 01/2018
1	Disease Progression 09/2015
1	Carcinoid Tumor (Carcinoid) 09/2015

Drug/Important Bio-Agent (IBA)

24	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 11/2018 - 12/2004
21	beta CateninIBA 10/2018 - 09/2006
20	Biomarkers (Surrogate Marker)IBA 01/2018 - 05/2010
14	NucleotidesIBA 12/2018 - 06/2008
12	MicroRNAs (MicroRNA)IBA 01/2017 - 03/2012
12	Fatty Acid Synthases (Fatty Acid Synthase)IBA 04/2011 - 12/2008
10	Cyclin D1IBA 03/2011 - 09/2006
9	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 09/2006
8	Calcibiotic Root Canal SealerIBA 01/2017 - 06/2007
5	ParaffinIBA 08/2014 - 06/2008
5	Cyclin-Dependent Kinases (cdk Proteins)IBA 06/2012 - 07/2009
5	Tumor Viral Antigens (Large T Antigen)IBA 03/2011 - 05/2008
5	Matrix Metalloproteinases (MMPs)IBA 09/2006 - 03/2004
5	Messenger RNA (mRNA)IBA 11/2005 - 03/2004
4	CateninsIBA 01/2018 - 03/2011
4	Codon (Codons)IBA 03/2017 - 01/2007
4	ErbB Receptors (EGF Receptor)IBA 03/2017 - 12/2012
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 11/2009
4	IGF Type 1 Receptor (IGF 1 Receptor)IBA 02/2014 - 12/2004
4	Insulin-Like Growth Factor II (Somatomedin A)IBA 02/2012 - 12/2004
4	Complementary DNA (cDNA)IBA 06/2007 - 12/2004
3	Vitamin D FDA LinkGeneric 11/2018 - 10/2009
3	MethyltransferasesIBA 03/2017 - 06/2007
3	Tumor Biomarkers (Tumor Markers)IBA 09/2015 - 06/2012
3	Phosphatidylinositols (Phosphatidylinositol)IBA 10/2012 - 06/2007
3	ElementsIBA 10/2012 - 04/2011
3	Insulin-Like PeptidesIBA 02/2012 - 12/2004
3	hydrogen sulfite (bisulfite)IBA 12/2010 - 11/2005
3	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 09/2006 - 03/2004
3	Matrix Metalloproteinase 7 (Matrilysin)IBA 12/2004 - 02/2003
2	Indicators and Reagents (Reagents)IBA 12/2018 - 12/2008
2	hydroxide ionIBA 11/2018 - 02/2016
2	25-hydroxyvitamin DIBA 11/2018 - 02/2016
2	Trastuzumab (Herceptin)FDA Link 01/2018 - 01/2014
2	LigandsIBA 01/2018 - 11/2017
2	Polycomb-Group ProteinsIBA 03/2017 - 03/2016
2	Enhancer of Zeste Homolog 2 ProteinIBA 03/2017 - 03/2016
2	AntigensIBA 01/2017 - 01/2016
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 11/2016 - 10/2012
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 11/2016 - 03/2010
2	Pharmaceutical PreparationsIBA 11/2016 - 03/2011
2	Dinoprostone (PGE2)FDA Link 01/2016 - 03/2010
2	Formaldehyde (Formol)FDA Link 08/2014 - 12/2012
2	Sirtuin 1IBA 11/2012 - 07/2009
2	Insulin-Like Growth Factor I (IGF-1)IBA 02/2012 - 12/2004
2	Cyclin-Dependent Kinase Inhibitor p16IBA 03/2011 - 12/2010
2	EnzymesIBA 11/2010 - 09/2006
2	TrypsinIBA 09/2003 - 02/2003
1	CalciumIBA 01/2019
1	polystyrene sulfonic acid (sodium polystyrene sulfonate)FDA LinkGeneric 06/2018
1	S-1 plus cisplatinIBA 01/2018
1	Interleukin-6 (Interleukin 6)IBA 01/2018
1	UbiquitinIBA 01/2018
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	B7-H1 AntigenIBA 11/2017
1	picropodophyllinIBA 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Eicosapentaenoic AcidIBA 09/2016
1	Docosahexaenoic AcidsIBA 09/2016
1	docosapentaenoic acidIBA 09/2016
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 09/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Untranslated RNA (Noncoding RNA)IBA 01/2016
1	Biological ProductsIBA 09/2015
1	Leukocyte Common Antigens (CD45 Antigen)IBA 08/2015
1	Nucleosomes (Nucleosome)IBA 04/2014

Therapy/Procedure

15	Therapeutics 02/2018 - 03/2010
4	Immunotherapy 01/2021 - 01/2016
2	Chemoprevention 03/2011 - 03/2010
1	Drug Therapy (Chemotherapy) 01/2017